BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34459916)

  • 1. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
    Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Eur J Pharmacol; 2021 Jan; 890():173663. PubMed ID: 33127361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Kumar H; Sharma BM; Sharma B
    Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):614-625. PubMed ID: 33480092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
    Ishola IO; Balogun AO; Adeyemi OO
    Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders.
    Gąssowska-Dobrowolska M; Cieślik M; Czapski GA; Jęśko H; Frontczak-Baniewicz M; Gewartowska M; Dominiak A; Polowy R; Filipkowski RK; Babiec L; Adamczyk A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
    Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
    J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
    Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
    Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
    Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
    Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress.
    Sharma N; Dhiman N; Golani LK; Sharma B
    Int J Dev Neurosci; 2021 Feb; 81(1):71-81. PubMed ID: 33175424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
    Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
    Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
    Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
    Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
    Kumar H; Sharma B
    Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
    Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
    ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.